Celldex Therapeutics, Inc. - CLDX
Ownership (Schedule 13D / 13G) · latest 50 filings
· Back to all files
Visible: 0
| Filed | Form | Reporting person | Percent | Shares | SEC |
|---|---|---|---|---|---|
| Mar 26, 2026 | SCHEDULE 13G/A | The Vanguard Group | 0.0% | 0 | View |
| Mar 10, 2026 | SCHEDULE 13G/A | Point72 Asset Management, L.P. | 2.6% | 1,758,357 | View |
| Mar 10, 2026 | SCHEDULE 13G/A | Point72 Capital Advisors, Inc. | 2.6% | 1,758,357 | View |
| Mar 10, 2026 | SCHEDULE 13G/A | Steven A. Cohen | 2.6% | 1,758,357 | View |
| Feb 10, 2026 | SCHEDULE 13G/A | Wellington Management Group LLP | 12.2% | 8,079,608 | View |
| Feb 10, 2026 | SCHEDULE 13G/A | Wellington Group Holdings LLP | 12.2% | 8,079,608 | View |
| Feb 10, 2026 | SCHEDULE 13G/A | Wellington Investment Advisors Holdings LLP | 12.2% | 8,079,608 | View |
| Feb 10, 2026 | SCHEDULE 13G/A | Wellington Management Company LLP | 11.8% | 8,079,608 | View |
| Feb 09, 2026 | SCHEDULE 13G | STATE STREET CORPORATION | 5.1% | 3,397,713 | View |
| Nov 14, 2025 | SCHEDULE 13G | Bellevue Group AG | 5.4% | 3,617,669 | View |
| Nov 14, 2025 | SCHEDULE 13G | Bellevue Asset Management AG | 5.4% | 3,617,669 | View |
| Nov 14, 2025 | SCHEDULE 13G/A | T. Rowe Price Associates, Inc. | 3.6% | 2,382,701 | View |
| Nov 14, 2025 | SCHEDULE 13G/A | Commodore Capital LP | 4.6% | 3,028,335 | View |
| Nov 14, 2025 | SCHEDULE 13G/A | Commodore Capital Master LP | 4.6% | 3,028,335 | View |
| Nov 07, 2025 | SCHEDULE 13G/A | Wellington Management Group LLP | 11.1% | 7,394,746 | View |
| Nov 07, 2025 | SCHEDULE 13G/A | Wellington Group Holdings LLP | 11.1% | 7,394,746 | View |
| Nov 07, 2025 | SCHEDULE 13G/A | Wellington Investment Advisors Holdings LLP | 11.1% | 7,394,746 | View |
| Nov 07, 2025 | SCHEDULE 13G/A | Wellington Management Company LLP | 10.8% | 7,394,746 | View |
Percent = "% of class represented by amount beneficially owned" for this reporting person in the filed 13D/13G.
Shares = reported beneficial ownership amount for the same row (not portfolio shares from 13F).
Amendments (/A) can repeat the same holder over time, so rows should not be summed.
Extraction is best-effort from filing text and can be missing or noisy; verify exact figures via the SEC link in each row.